13
total announcements
539872.BO · 15 min delayed
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has announced the dispatch of notice of 33rd Annual General Meeting and Annual Report for the financial year 2025-26, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has dispatched a letter to shareholders who have not registered their email addresses, providing a web-link to access the Annual Report 2025-26. The company also reminds shareholders to update their KYC details and dematerialize physical securities.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has released its Business Responsibility and Sustainability Report for the financial year 2025-26, as per SEBI regulations.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has announced the dispatch of its Annual Report for the financial year 2025-26 and scheduled its 33rd Annual General Meeting for September 21, 2026.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has announced its 33rd Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing. The company has also dispatched its Annual Report for the financial year 2025-26 to shareholders.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has announced the 33rd Annual General Meeting (AGM) to be held on September 21, 2026, through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The company has also published a notice regarding the compulsory transfer of equity shares to the Investor Education and Protection Fund (IEPF) due to unpaid dividend for seven consecutive years or more.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has allotted 2,500 equity shares to eligible employees under the Bajaj Healthcare Limited Employee Stock Option Scheme 2024, following the exercise of 2,500 vested stock options at an exercise price of ₹5 per stock option.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has received approval from the Drug Controller General of India (DCGI) to manufacture and market Cenobamate API and Tablets in six strengths, making it the first company to launch Cenobamate in India.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd's bank loan facilities have been upgraded to 'IND A' with a stable outlook and 'IND A1' for short-term facilities by India Ratings and Research (Ind-Ra) due to the company's strengthened business and operational profile, marked by healthy order visibility and sustained gross margins.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has announced the transcript of its Q1FY27 earnings call, highlighting its strategic focus on API and formulation businesses, including expansion into high-value science-led APIs and oncology APIs, and strengthening its formulation business through the acquisition of GenRx Pharmaceutical manufacturing facility.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has published its un-audited financial results for the quarter ended June 30, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has uploaded the audio recording of its Q1FY27 earnings call on its website.
Bajaj Healthcare Ltd
Bajaj Healthcare Ltd has approved the sale of an operational business unit located in Tarapur, Boisar, Palghar, to M/s Orchem Products. This unit contributed a minor 0.54% to the company's revenue (₹3.31 Crores) and 0.74% to its net worth (₹3.97 Crores) in the last financial year. The sale consideration is up to ₹4.05 Crores, and the transaction is expected to be completed by October 31, 2026. The company confirmed it is not a related party transaction.